These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 2045705)

  • 1. Unprecedented high catecholamine production causing hair pigmentation after urinary excretion in red deer.
    Galván I; Solano F; Zougagh M; de Andrés F; Murtada K; Ríos Á; de la Peña E; Carranza J
    Cell Mol Life Sci; 2019 Jan; 76(2):397-404. PubMed ID: 30413834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by amphetamine of testosterone secretion through a mechanism involving an increase of cyclic AMP production in rat testes.
    Tsai SC; Chiao YC; Lu CC; Doong ML; Chen YH; Shih HC; Liaw C; Wang SW; Wang PS
    Br J Pharmacol; 1996 Jun; 118(4):984-8. PubMed ID: 8799572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral catecholamine metabolites and menstrual irregularity in patients with polycystic ovaries.
    Yoshino K; Takahashi K; Eda Y; Nishigaki A; Kitao M
    Int J Fertil Menopausal Stud; 1993; 38(4):225-8. PubMed ID: 8401681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in plasma catecholamines and pulsatile patterns of gonadotropin release in subjects with a normal ovulatory cycle and with polycystic ovary syndrome.
    Yoshino K; Takahashi K; Shirai T; Nishigaki A; Araki Y; Kitao M
    Int J Fertil; 1990; 35(1):34-9. PubMed ID: 1968442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma catecholamine metabolites and polycystic ovary syndrome.
    Yoshino K; Takahashi K; Nishigaki A; Eda Y; Kitao M
    Asia Oceania J Obstet Gynaecol; 1990 Mar; 16(1):57-62. PubMed ID: 2111696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence concerning catecholamine metabolism in polycystic ovary syndrome following Gn-RH administration.
    Yoshino K; Takahashi K; Nishigaki A; Eda Y; Kitao M
    Int J Fertil; 1992; 37(2):111-4. PubMed ID: 1349592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of TJ-68 (shakuyaku-kanzo-to) on polycystic ovarian disease.
    Takahashi K; Kitao M
    Int J Fertil Menopausal Stud; 1994; 39(2):69-76. PubMed ID: 8012442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic ovary syndrome.
    Franks S
    J R Coll Physicians Lond; 1998; 32(2):111-3. PubMed ID: 9597623
    [No Abstract]   [Full Text] [Related]  

  • 9. Peripheral catecholamine metabolites and free testosterone in patients with polycystic ovary syndrome.
    Yoshino K; Takahashi K; Eda Y; Nishigaki A; Kitao M
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):351-4. PubMed ID: 2045705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
    McCartney CR; Eagleson CA; Marshall JC
    Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.